US Patent

US6812238 — N-substituted carbamoyloxyalkyl-azolium derivatives

Composition of Matter · Assigned to Basilea Pharmaceutica AG · Expires 2025-10-31 · 1y expired

Vulnerability score 7/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects N-substituted carbamoyloxyalkyl-azolium derivatives, which have antifungal activity and are useful for treating fungal diseases.

USPTO Abstract

N-substituted carbamoyloxyalkyl-azolium derivatives which have antifungal activity and are useful for the treatment of fungal diseases.

Drugs covered by this patent

isavuconazonium-sulfate (ISAVUCONAZONIUM SULFATE)

Patent Metadata

Patent number: US6812238
Jurisdiction: US
Classification: Composition of Matter
Expires: 2025-10-31
Drug substance claim: Yes
Drug product claim: No
Assignee: Basilea Pharmaceutica AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.